Compare Mesoblast Limited (MESO) vs Paychex, Inc. (PAYX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs Paychex, Inc. — how do they compare? Mesoblast Limited trades at $16.68 (market cap $2.21B), while Paychex, Inc. trades at $120.92 (market cap $43.14B). The key difference: Paychex, Inc. is far larger — about 19.5× Mesoblast Limited's market cap, and Paychex, Inc. pays a 3.92% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| MESO | PAYX | |
|---|---|---|
Market Cap | $2.21B | $43.14B |
Sector | Technology | Industrials |
52-Week High | $20.96 | $140.81 |
52-Week Low | $12.88 | $85.57 |
Enterprise Value | $2.21B | $46.63B |
Dividend Yield | — | 3.92% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About Paychex, Inc.
Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, established in 1979, services over 730,000 clients and pays over 1 in 12 U.S. private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.
Read more on PAYX →
